Abstract 242P
Background
In India head and neck cancers (HNCs) are the most common cancer among male and rank 2nd overall. There is wide variation in the incidence and anatomic distribution of HNCs in India compared to western countries. This variation is mostly due to demographic differences in cigarette and alcohol consumption behaviours, which lead to the development of over 80% of all HNCs diagnosed worldwide. The purpose of this study was to understand the epidemiology of HNCs in terms of demographic and clinical characteristics at the time of diagnosis and their survival.
Methods
This was a retrospective single-center, hospital-based cancer registry study which included all primary diagnosed HNCs cases attending various departments of our hospital during the time 1st January 2016 – 31st December 2020. Patients’ sociodemographic characteristics, clinicopathological details, such as stage of cancer, treatment received and follow up details were extracted from medical records. All statistical analysis was performed using Microsoft Excel 2016 and R software (Rx 64 version 3.6.2). Survival was estimated by the Kaplan Meier method and compared by the log-rank test.
Results
A total of 574 confirmed cases of HNCs were include in this study. Baseline characteristics of patients are listed in the table. Majority of the patients presented as locally advanced disease. The treatment intent was curative in 80% and palliative for 20%. The median follow up period was 20.0 months (inter quartile range of 12.0). After 18 months of follow up 58.5% of the cases survived. There was no statistically significant difference in survival between male and female, tobacco users and non-tobacco users, age below and above 60 years. The survival was statistically significant in patients with histological grade I and II compared to grade III tumours.
Conclusions
This study reports the demographic profile and pattern of care of patients with HNCs from a comprehensive care center in North India. Table: 242P
Baseline distribution of HNCs (N = 574)
Age, years (range) | 56 (24-91) |
Tobacco history | |
Yes | 492 (86%) |
No | 82 (14%) |
Site distribution | |
Oral cavity including lip | 223 (39%) |
Oropharynx | 176 (31%) |
Larynx and hypopharynx | 140(24%) |
Nasopharynx | 23 (4%) |
Salivary gland | 7 (1%) |
Nasal cavity and paranasal sinuses | 5 (1%) |
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
214P - Versican G3 domain promotes myeloma cell proliferation, migration and invasion via activation of FAK/STAT3 signaling
Presenter: Nidhi Gupta
Session: Poster viewing 03
215P - Prospective observational study to evaluate impact of metabolic tumor volume on baseline 18F FDG PET/CT and molecular markers on tumor response rate in patients with diffuse large B-cell lymphoma
Presenter: Ankur Mudgal
Session: Poster viewing 03
216P - Lenalidomide maintenance after whole brain radiotherapy in relapsed/refractory primary CNS lymphoma
Presenter: Bhausaheb Bagal
Session: Poster viewing 03
217P - Role of copper levels in patients with myelodysplastic syndromes
Presenter: Revanth Boddu
Session: Poster viewing 03
218P - Prognostic role of apoptotic index in acute lymphoblastic leukemia
Presenter: Ramya Ramesh
Session: Poster viewing 03
219TiP - Randomised controlled study to compare efficacy & safety of KRd versus VRd regimens in newly diagnosed multiple myeloma using weekly schedule of generic carfilzomib
Presenter: Jasmine Porwal
Session: Poster viewing 03
233P - Cancer awareness, tobacco use and cessation among Malayali tribes, Yelagiri Hills, Tamil Nadu, India: A 8-year follow up study
Presenter: Delfin Lovelina Francis
Session: Poster viewing 03
234P - Epithelial-mesenchymal transition and cancer stem cells: Missing link in oral squamous cell carcinoma
Presenter: Selvaraj Jayaraman
Session: Poster viewing 03
235P - Evaluation of a prognostic model for head and neck cutaneous squamous cell carcinoma using a cumulative number of risk factors
Presenter: Reiichi Doi
Session: Poster viewing 03